XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities [Yahoo! Finance]
XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities
XOMA Co. (NASDAQ: XOMA) had its "outperform" rating re-affirmed by analysts at Leerink Partnrs.
XOMA Co. (NASDAQ: XOMA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $74.00 price target on the stock.
XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2% [Yahoo! Finance]